IJDDC

Loading...

IJDDC

IJDDC

International Journal Diabetes in Developing Countries

A randomized, double‑blind, active‑controlled trial assessing the efficacy and safety of a fixed‑dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial

A randomized, double‑blind, active‑controlled trial assessing the efficacy and safety of a fixed‑dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial Download PDF